View in EDS HTML Full Text PDF Full Text

Real‐world outcomes of cisplatin, capecitabine, and gemcitabine with either epirubicin (PEXG) or docetaxel (PDXG) as first‐line palliative treatment in metastatic or unresectable locally advanced pancreatic adenocarcinoma.

Saved in:
Bibliographic Details
Title: Real‐world outcomes of cisplatin, capecitabine, and gemcitabine with either epirubicin (PEXG) or docetaxel (PDXG) as first‐line palliative treatment in metastatic or unresectable locally advanced pancreatic adenocarcinoma.
Authors: Hitchen, Nadia1,2 (AUTHOR) NHitchen@adhb.govt.nz, Waldron, Nick R.1 (AUTHOR), Deva, Sanjeev1,2 (AUTHOR), Findlay, Michael1,2 (AUTHOR), Lawrence, Benjamin1,2 (AUTHOR)
Source: Asia Pacific Journal of Clinical Oncology. Oct2023, Vol. 19 Issue 5, pe231-e238. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 172273652
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Real‐world outcomes of cisplatin, capecitabine, and gemcitabine with either epirubicin (PEXG) or docetaxel (PDXG) as first‐line palliative treatment in metastatic or unresectable locally advanced pancreatic adenocarcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Hitchen%2C+Nadia%22">Hitchen, Nadia</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> NHitchen@adhb.govt.nz</i><br /><searchLink fieldCode="AR" term="%22Waldron%2C+Nick+R%2E%22">Waldron, Nick R.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Deva%2C+Sanjeev%22">Deva, Sanjeev</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Findlay%2C+Michael%22">Findlay, Michael</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lawrence%2C+Benjamin%22">Lawrence, Benjamin</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Asia+Pacific+Journal+of+Clinical+Oncology%22">Asia Pacific Journal of Clinical Oncology</searchLink>. Oct2023, Vol. 19 Issue 5, pe231-e238. 8p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=172273652
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/ajco.13845
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 8
        StartPage: e231
    Titles:
      – TitleFull: Real‐world outcomes of cisplatin, capecitabine, and gemcitabine with either epirubicin (PEXG) or docetaxel (PDXG) as first‐line palliative treatment in metastatic or unresectable locally advanced pancreatic adenocarcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hitchen, Nadia
      – PersonEntity:
          Name:
            NameFull: Waldron, Nick R.
      – PersonEntity:
          Name:
            NameFull: Deva, Sanjeev
      – PersonEntity:
          Name:
            NameFull: Findlay, Michael
      – PersonEntity:
          Name:
            NameFull: Lawrence, Benjamin
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: Oct2023
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 17437555
          Numbering:
            – Type: volume
              Value: 19
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Asia Pacific Journal of Clinical Oncology
              Type: main
ResultId 1